# Nifedipine

## Alat 10mg

##### 

| TAH Drug Code      | OALA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension, chronic stable angina pectoris                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | HTN, angina 10-20mg TID, maximum 180mg.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | CV shock; pregnancy & lactation. Unstable angina & after recent MI (immediate release).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Initially mild & transient vasodilatation, hypotension, rarely GI, skin & other reactions. Very rarely: transient visual change; chest discomfort (if relation established, discontinue therapy). Extremely rare: on prolonged use gingival hyperplasia, gynaecomastia (both regressing on discontinuation); hepatobiliary disorders. Cardiovascular: Hypotension (up to 5% ), Palpitations (up to 7% ), Peripheral edema (7% to 29% ) Dermatologic: Flushing (4% to 25%) Gastrointestinal: Nausea (up to 10% ) Neurologic: Dizziness (4% to 10% ), Headache (19% to 23%) Psychiatric: Feeling nervous Respiratory: Cough, Dyspnea |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

## Nifedipine S.R.F.C. 30mg

##### 

| TAH Drug Code      | ONIF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension, chronic stable angina pectoris                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | angina: 30mg QD. HTN: 30mg QD up to 120mg.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | CV shock; pregnancy & lactation. Unstable angina & after recent MI (immediate release).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Initially mild & transient vasodilatation, hypotension, rarely GI, skin & other reactions. Very rarely: transient visual change; chest discomfort (if relation established, discontinue therapy). Extremely rare: on prolonged use gingival hyperplasia, gynaecomastia (both regressing on discontinuation); hepatobiliary disorders. Cardiovascular: Hypotension (up to 5% ), Palpitations (up to 7% ), Peripheral edema (7% to 29% ) Dermatologic: Flushing (4% to 25%) Gastrointestinal: Nausea (up to 10% ) Neurologic: Dizziness (4% to 10% ), Headache (19% to 23%) Psychiatric: Feeling nervous Respiratory: Cough, Dyspnea |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

